title: Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease.
authors.forename: Hans
authors.initials: H
authors.lastname: Herfarth
authors.forename: Florian
authors.initials: F
authors.lastname: Obermeier
authors.forename: Tilo
authors.initials: T
authors.lastname: Andus
authors.forename: Gerhard
authors.initials: G
authors.lastname: Rogler
authors.forename: Susanna
authors.initials: S
authors.lastname: Nikolaus
authors.forename: Tanja
authors.initials: T
authors.lastname: Kuehbacher
authors.forename: Stefan
authors.initials: S
authors.lastname: Schreiber
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018771:Arthralgia / Q000150:complications / Q000175:diagnosis*; D001168:Arthritis / Q000150:complications / Q000175:diagnosis*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab